GW-493838

CAS No. 253124-46-8

GW-493838( —— )

Catalog No. M34277 CAS No. 253124-46-8

GW-493838 is a potent adenosine A1A receptor agonist for the treatment of dyslipidemia and neuropathic pain, with analgesic effects on post-herpetic neuralgia or peripheral nerve damage caused by trauma or surgery.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 234 Get Quote
5MG 366 Get Quote
10MG 520 Get Quote
25MG 756 Get Quote
50MG 1021 Get Quote
100MG 1350 Get Quote
500MG 2646 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GW-493838
  • Note
    Research use only, not for human use.
  • Brief Description
    GW-493838 is a potent adenosine A1A receptor agonist for the treatment of dyslipidemia and neuropathic pain, with analgesic effects on post-herpetic neuralgia or peripheral nerve damage caused by trauma or surgery.
  • Description
    GW-493838 is a potent adenosine A1A receptor agonist for the treatment of dyslipidemia and neuropathic pain, with analgesic effects on post-herpetic neuralgia or peripheral nerve damage caused by trauma or surgery.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adenosine Receptor
  • Recptor
    Adenosine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    253124-46-8
  • Formula Weight
    489.89
  • Molecular Formula
    C21H21ClFN7O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@H]1[C@H](N2C=3C(N=C2)=C(NC4=C(F)C=C(Cl)C=C4)N=CN3)O[C@@H]([C@H]1O)C=5OC(C(C)(C)C)=NN5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tozadenant

    A potent, selective adenosine 2A receptor (A2A/NR2B) antagonist with Ki of 11.5 nM.

  • GS-9667

    GS-9667, a selective and partial agonist of the A(1) adenosine receptor (AR), represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA).

  • MRE3008F20

    MRE3008F20 is a species-selective and potent adenosine A3 receptor (AA3R) antagonist that inhibits Cl-IB-MECA-induced cAMP production and can be used in glaucoma and asthma studies.CAS ??13483-88-88-9